$10.58
+0.06 (+0.57%)
Open$10.51
Previous Close$10.52
Day High$11.98
Day Low$10.21
52W High$34.27
52W Low$3.92
Volume—
Avg Volume129.0K
Market Cap68.27M
P/E Ratio—
EPS$-31.60
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+264.2% upside
Current
$10.58
$10.58
Target
$38.53
$38.53
$25.32
$38.53 avg
$55.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 17.69M | 19.09M | 16.86M |
| Net Income | -209,788,904 | -203,766,472 | 3.00M |
| Profit Margin | -1,185.8% | -1,126.5% | 17.8% |
| EBITDA | -204,209,237 | -209,366,258 | 6.50M |
| Free Cash Flow | — | — | 2.15M |
| Rev Growth | -7.3% | -7.3% | +5.1% |
| Debt/Equity | — | — | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |